Sylvest Advisors’s Johnson & Johnson JNJ Stock Holding History

Sylvest Advisors’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5,850	Closed	-$1.43M	–	80
2026 Q1	$1.43M	Sell	5,850 -101	-2%	-$23.5K	0.76%	16
2025 Q4	$1.23M	Buy	5,951 +125	+2%	+$24.7K	0.66%	18
2025 Q3	$1.08M	Buy	5,826 +386	+7%	+$66.1K	0.58%	20
2025 Q2	$831K	Buy	5,440 +19	+0.4%	+$2.92K	0.48%	24
2025 Q1	$899K	Sell	5,421 -62	-1%	-$9.7K	0.56%	24
2024 Q4	$793K	Buy	+5,483	New	+$850K	0.49%	30

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Sylvest Advisors's JNJ Position: Q2 2026 in Review

Sylvest Advisors sold out of Johnson & Johnson (JNJ) in Q2 2026, closing a stake of 5,850 shares — an estimated $1.43M sold.

Sylvest Advisors first reported a position in JNJ in Q4 2024 and held it in 6 quarters. The position peaked at $1.43M in Q1 2026. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Sylvest Advisors reported no remaining Johnson & Johnson position as of Q2 2026 after selling out during the quarter.
Sylvest Advisors sold 5,850 Johnson & Johnson shares in Q2 2026, an estimated $1.43M.
Sylvest Advisors first reported a position in Johnson & Johnson in Q4 2024 and held it in 6 quarters.
Sylvest Advisors's Johnson & Johnson position peaked at $1.43M in Q1 2026.
4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Sylvest Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.